Drug intelligence / Profile preview

Cannabiol

Development stage: Unknown
Lead developer: Knop Laboratorios
Modality: Small Molecules
Administration: Oral, Oromucosal, Sublingual, Buccal, Inhalation, Topical, Rectal, Transdermal, Intramuscular, Ophthalmic, Intranasal

Overview

**Cannabiol** is a prescription oral oily solution developed and manufactured by Knop Laboratorios from standardized *Cannabis sativa* extracts containing the phytocannabinoids cannabidiol and tetrahydrocannabinol. It is a fixed-dose cannabinoid product intended as an adjunct for refractory neuropathic pain and refractory pain in patients with terminal cancer; it received Peruvian sanitary registration PNE-1655. The product has also been studied for cancer pain and reported as under development for osteoarthritis and fibromyalgia. ([knoplabs.com](https://www.knoplabs.com/knop-laboratorios-obtiene-autorizacion-sanitaria-en-peru-para-comercializar-el-primer-medicamento-chileno-a-base-de-cannabis/))

Brand names: Cannabiol
Other names: Cannabiol solución oleosa

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Cannabiol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cannabiol.

Explore the full profile